본문 바로가기
KERD
논문KCI 등재

당뇨병성 신증에 대한 진단 및 검사

Diagnosis and test for diabetic kidney disease

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Diabetic kidney disease, as one of the important diabetic complication, developed in 20% to 40% of patients with diabetes and is now the most common cause of end-stage renal disease. Although it has been recommended that annual screening of renal function including microalbuminuria in diabetic patients, many patients are currently under-diagnosed state. Early recognition of diabetic renal complication has a pivotal role in the management of diabetic patients for improvement of patient's prognosis. The detection of microalbuminuria is particularly important as a marker of early diabetic kidney disease, and is related with an elevated cardiovascular complications. Like other chronic renal disease, diabetic kidney disease has characteristic to show a progressive decline in renal function, but significantly increased cardiovascular mortality even in the early stage of diabetic kidney disease. Therefore, more aggressive trials for detection of the presence of diabetic kidney disease and comorbid cardiovascular disease and management for cardiovascular risk factor reduction and adequate therapeutic intervention for slowing the progression of renal disease is essential to proper management for patients with diabetic kidney disease.

Abstract

Diabetic kidney disease, as one of the important diabetic complication, developed in 20% to 40% of patients with diabetes and is now the most common cause of end-stage renal disease. Although it has been recommended that annual screening of renal function including microalbuminuria in diabetic patients, many patients are currently under-diagnosed state. Early recognition of diabetic renal complication has a pivotal role in the management of diabetic patients for improvement of patient's prognosis. The detection of microalbuminuria is particularly important as a marker of early diabetic kidney disease, and is related with an elevated cardiovascular complications. Like other chronic renal disease, diabetic kidney disease has characteristic to show a progressive decline in renal function, but significantly increased cardiovascular mortality even in the early stage of diabetic kidney disease. Therefore, more aggressive trials for detection of the presence of diabetic kidney disease and comorbid cardiovascular disease and management for cardiovascular risk factor reduction and adequate therapeutic intervention for slowing the progression of renal disease is essential to proper management for patients with diabetic kidney disease.

참고문헌 (53)

  1. KDOQI, "KDOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease", Am J Kidney Dis, 49, pp.S12~S154 (2007)
  2. Coresh J, "Prevalence of chronic kidney disease in the United States", JAMA, 298, pp.2038~2047 (2007)
  3. Middleton RJ, "The unrecognized prevalence of chronic kidney disease in diabetes", Nephrol Dial Transplant, 21, pp.88~92 (2006)
  4. McClellan WM, "Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines", 29, pp.368~375 (1997)
  5. Chaturvedi N, "Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold", Kidney Int, 60, pp.219~227 (2001)
  6. Hovind P, "Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study", BMJ, 328, pp.1105~ (2004)
  7. Adler AI, "Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)", Kidney Int, 63, pp.225~232 (2003)
  8. Andersen AR, "Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study", Diabetologia, 25, pp.496~501 (1983)
  9. Wong TY, "Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes", Diabetes, 53, pp.179~184 (2004)
  10. Levey AS, "National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification", Ann Intern Med, 139, pp.137~147 (2003)
  11. Weiner DE, "Kidney disease as a risk factor for recurrent cardiovascular disease and mortality", Am J Kidney Dis, 44, pp.198~206 (2004)
  12. Go AS, "Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization", N Engl J Med, 351, pp.1296~1305 (2004)
  13. Nelson RG, "Development and progression of renal disease in Pima Indians with noninsulin-dependent diabetes mellitus", N Engl J Med, 335, pp.1636~1642 (1996)
  14. Poulsen PL, "Ambulatory blood pressure in the transition from normo- to microalbuminuria: a longitudinal study in IDDM patients", Diabetes, 43, pp.1248~1253 (1994)
  15. Microalbuminuria Collaborative Study Group, "United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study", BMJ, 306, pp.1235~1239 (1993)
  16. Nelson RG, "Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulindependent)", diabetes mellitus in Pima Indians. Diabetologia, 36, pp.998~1001 (1993)
  17. Klausen K, "Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension,and diabetes", Circulation, 110, pp.32~35 (2004)
  18. Gerstein HC, "Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals", JAMA, 286, pp.421~426 (2001)
  19. Dinneen SF, "The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature", Arch Intern Med, 157, pp.1413~1418 (1997)
  20. American Diabetes Association, "Standards of medical care in diabetes: 2007", Diabetes Care, 30(1), pp.S4~S41 (2007)
  21. Kidney Disease Outcomes Quality Initiative (K, "DOQI)", K, Am J Kidney Dis, pp.2004, 43(1)[DOI]
  22. Ahn CW, "The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy", YonseiMed, 40, pp.40~45 (1999)
  23. Nathan DM, "Single-void urine samples can be used to estimate quantitative microalbuminuria", Diabetes Care, 10, pp.414~418 (1987)
  24. Zelmanovitz T, "The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy", Diabetes Care, 20, pp.516~519 (1997)
  25. Mogensen CE, "Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion", Diabetes Care, 18, pp.572~581 (1995)
  26. Feldt-Rasmussen B, "Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies", Dan Med Bull, 36, pp.405~415 (1989)
  27. European Diabetes Policy Group 1999, "A desktop guide to type 2 diabetes", Diabet Med, 16, pp.716~730 (1999)
  28. Comper WD, "Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay", Kidney Int, 65, pp.1850~1855 (2004)
  29. Forsblom CM, "Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM", Diabetes Care, 21, pp.1932~1938 (1998)
  30. Murussi M, "Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study", Diabetes Care, 25, pp.1101~1103 (2002)
  31. The Microalbuminuria Collaborative Study Group, "Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a sevenyear prospective study", Diabet Med, 16, pp.918~925 (1999)
  32. Stephenson JM, "Microalbuminuria is not rare before 5 years of IDDM: EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group", J Diabetes Complications, 8, pp.166~173 (1994)
  33. Schultz CJ, "Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study: Oxford Regional Prospective Study Group", Diabetes Care, 22, pp.495~502 (1999)
  34. Caramori ML, "Cellular basis of diabetic nephropathy: 1. study design and renal structural-functional relationships in patients with long-standing type 1 diabetes", Diabetes, 51, pp.506~513 (2002)
  35. Basi S, "Microalbuminuria as a target to improve cardiovascular and renal outcomes", Am J Kidney Dis, 47, pp.927~946 (2006)
  36. Dalla Vestra M, "Structural involvement in type 1 and type 2 diabetic nephropathy", Diabetes Metab, 26(4), pp.8~14 (2000)
  37. Kramer HJ, "Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus", JAMA, 289, pp.3273~3277 (2003)
  38. Caramori ML, "Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions", Diabetes, 52, pp.1036~1040 (2003)
  39. MacIsaac RJ, "Nonalbuminuric renal insufficiency in type 2 diabetes", Diabetes Care, 27, pp.195~200 (2004)
  40. 11), "Diabetes Care", 2009, 1497~1502
  41. Perrone RD, "Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study", Am J Kidney Dis, 16, pp.224~235 (1990)
  42. Rossing P, "Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy", Diabetes Care, 29, pp.1024~1030 (2006)
  43. Fontsere N, "Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?", Nephrol Dial Transplant, 21, pp.2152~2158 (2006)
  44. Mussap M, "Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients", Kidney Int, 61, pp.1453~1461 (2002)
  45. Perkins BA, "Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study", J Am Soc Nephrol, 16, pp.1404~1412 (2005)
  46. Christensen PK, "Renal function and structure in albuminuric type 2 diabetic patients without retinopathy", Nephrol Dial Transplant, 16, pp.2337~2347 (2001)
  47. Mauer M, "Diabetic nephropathy. In: Diseases of the kidney and urinary tract. 7th ed", pp.2083~2116 (2001), Lippincott Williams & Wilkins
  48. Wong TY, "Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies", Diabetes Care, 25, pp.900~905 (2002)
  49. Gall MA, "Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study", BMJ, 314, pp.783~788 (1997)
  50. Gross JL, "Silveiro SP, Azevedo MJ, Friedman R. Risk factors for development of proteinuria in type II (non-insullin dependent) diabetic patients", Braz J Med Biol Res, 26, pp.1269~1278 (1993)
  51. Parving HH, "Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients", Kidney Int, 41, pp.758~762 (1992)
  52. Valabhji J, "Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension", Diabetes Care, 23, pp.539~543 (2000)
  53. Nicholls AJ, "The impact of atherosclerotic renovascular disease on diabetic renal failure", Diabet Med, 19, pp.889~894 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (14건)